Resilience Strategies and the Pharmaceutical Supply Chain: The Role of Agility in Mitigating Drug Shortages

Emilia Vann Yaroson, Liz Breen, Jiachen Hou, Julie Sowter

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

6 Citations (Scopus)

Abstract

Supply chain resilience has been suggested to curb the impact of disruptions on supply chains. While this proposition seems coherent in theory, empirical evidence supporting this is limited, as existing literature has centred on exploring the impact of supply chain resilience on disruptions which are based on set time frames, non-supply chain specific as well as examining non-dynamic disruptive events. This study contends that resilience strategies are dynamic and as such their applications within supply chains differ. Therefore examining the impact of resilience will be appropriate on a dynamic disruption within a specific supply chain. In view of this, the paper examines through existing literature the applicability of agility within the pharmaceutical supply chain when dynamic disruptions like drug shortages occur. The study finds alertness, accessibility, connectivity and visibility as dimensions of supply chain agility that are capable of reducing the impact of drug shortages.
Original languageEnglish
Title of host publicationPharmaceutical Supply Chains - Medicine Shortages
EditorsAna Paula Barbosa-Povoa, Helena Jenzer, João Luís de Miranda
PublisherSpringer, Cham
Chapter18
Pages249-256
Number of pages8
Edition1st
ISBN (Electronic)9783030153984
ISBN (Print)9783030153977, 9783030154004
DOIs
Publication statusPublished - 2 Jun 2019
Externally publishedYes

Publication series

NameLecture Notes in Logistics
PublisherSpringer
ISSN (Print)2194-8917
ISSN (Electronic)2194-8925

Fingerprint

Dive into the research topics of 'Resilience Strategies and the Pharmaceutical Supply Chain: The Role of Agility in Mitigating Drug Shortages'. Together they form a unique fingerprint.

Cite this